Literature DB >> 16008119

The effect of adlay oil on plasma lipids, insulin and leptin in rat.

B W Huang1, M T Chiang, H T Yao, W Chiang.   

Abstract

This study was designed to investigate the effect of dietary adlay oil on plasma lipids, insulin and lipid peroxidation levels in rats. Twenty-four male Wistar rats fed diet containing adlay oil and cholesterol were studied for 4 weeks. The animals were divided into three groups: (1) 10% lard (control) group; (2) 5% lard + 5% adlay oil (5% adlay oil) group; and (3) 10% adlay oil group. Although there was no significant difference in body weight at the end of the feeding study, rats fed a diet containing adlay oil showed a significant decrease in adipose tissue weight and relative adipose weight. In addition, the rats fed the adlay oil showed significantly decreased low-density lipoprotein cholesterol (LDL-C), insulin, leptin and thiobarbituric acid reactive substance (TBARS) concentrations after 4 weeks of the feeding study. Although a significant decrease in total plasma cholesterol was observed in rats fed the 5% adlay oil diet, no significant difference was observed between the 10% adlay oil and control groups, and neither was a significant difference in liver TBARS concentration found between the dietary groups. Results from this study suggest that dietary adlay oil can reduce leptin, adipose tissue and LDL-C levels in rats.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16008119     DOI: 10.1016/j.phymed.2004.02.010

Source DB:  PubMed          Journal:  Phytomedicine        ISSN: 0944-7113            Impact factor:   5.340


  9 in total

1.  Effects of crude adlay hull acetone extract on corticosterone release from rat zona fasciculata-reticularis cells.

Authors:  Ling-Ling Chang; Alfred Wan-Song Wun; Chien-Te Hung; Shih-Min Hsia; Wenchang Chiang; Paulus S Wang
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-09-21       Impact factor: 3.000

2.  Effects of adlay, buckwheat, and barley on transit time and the antioxidative system in obesity induced rats.

Authors:  Jung Yun Kim; Bo Kyung Son; Sang Sun Lee
Journal:  Nutr Res Pract       Date:  2012-06-30       Impact factor: 1.926

3.  Osteoporosis Prevention by Adlay ( Yì Yǐ: The Seeds of Coix Lachryma-Jobi L. var. ma-yuen Stapf) in a Mouse Model.

Authors:  Rong-Sen Yang; Yi-Hsiang Lu; Wenchang Chiang; Shing-Hwa Liu
Journal:  J Tradit Complement Med       Date:  2013-04

Review 4.  Adlay ( yì yĭ; "soft-shelled job's tears"; the seeds of Coix lachryma-jobi L. var. ma-yuen Stapf) is a Potential Cancer Chemopreventive Agent toward Multistage Carcinogenesis Processes.

Authors:  Ching-Chuan Kuo; Huang-Hui Chen; Wenchang Chiang
Journal:  J Tradit Complement Med       Date:  2012-10

5.  De novo transcriptome assembly of the Chinese pearl barley, adlay, by full-length isoform and short-read RNA sequencing.

Authors:  Sang-Ho Kang; Jong-Yeol Lee; Tae-Ho Lee; Soo-Yun Park; Chang-Kug Kim
Journal:  PLoS One       Date:  2018-12-11       Impact factor: 3.240

6.  Food-Drug Interaction between the Adlay Bran Oil and Drugs in Rats.

Authors:  Hsien-Tsung Yao; Jia-Hsuan Lin; Yun-Ta Liu; Mei-Ling Li; Wenchang Chiang
Journal:  Nutrients       Date:  2019-10-15       Impact factor: 5.717

Review 7.  Actional Mechanisms of Active Ingredients in Functional Food Adlay for Human Health.

Authors:  Yawen Zeng; Jiazhen Yang; Jia Chen; Xiaoying Pu; Xia Li; Xiaomeng Yang; Li'e Yang; Yumei Ding; Mingying Nong; Shibao Zhang; Jinbao He
Journal:  Molecules       Date:  2022-07-27       Impact factor: 4.927

8.  Assessment of the Genetic Diversity of Different Job's Tears (Coix lacryma-jobi L.) Accessions and the Active Composition and Anticancer Effect of Its Seed Oil.

Authors:  Xiu-Jie Xi; Yun-Guo Zhu; Ying-Peng Tong; Xiao-Ling Yang; Nan-Nan Tang; Shu-Min Ma; Shan Li; Zhou Cheng
Journal:  PLoS One       Date:  2016-04-12       Impact factor: 3.240

9.  Prophylactic Treatment with Adlay Bran Extract Reduces the Risk of Severe Acute Radiation Dermatitis: A Prospective, Randomized, Double-Blind Study.

Authors:  Chih-Jen Huang; Ming-Feng Hou; Jung-Yu Kan; Chiung-Hui Juan; Shyng-Shiou F Yuan; Kuei-Hau Luo; Hung-Yi Chuang; Stephen Chu-Sung Hu
Journal:  Evid Based Complement Alternat Med       Date:  2015-10-01       Impact factor: 2.629

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.